Metraipolis › archive › dc_3f7e03cd31be

Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia — Europe PMC PMID:41598845

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41598845
DOI
10.3390/jcm15020908
License (as archived)
solo-consultazione
Archived
2026-11-06T13:44:53.975Z
SHA-256 of the archived text
a0cc2f397b04d893a384e0bf12021c2384cd43d8108017a31f1ef4ad09794dc1
Stable URL of this page
https://metraipolis.com/documento/dc_3f7e03cd31be

How to cite

Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia — Europe PMC PMID:41598845 — Europe PMC (en), https://europepmc.org/article/MED/41598845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f7e03cd31be (Metraipolis archive dc_3f7e03cd31be, sha256 a0cc2f397b04d893a384e0bf12021c2384cd43d8108017a31f1ef4ad09794dc1)
BibTeX
@misc{dc3f7e03cd31be,
  title = {Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia — Europe PMC PMID:41598845},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598845},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f7e03cd31be; sha256 a0cc2f397b04d893a384e0bf12021c2384cd43d8108017a31f1ef4ad09794dc1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598845. Agents can read the archived copy with the MCP tool read_document.